ACCESS TO MEDICINEs IN EMERGING MARKETS
MAEM
Global Health Organization
Advancing Access to Medicines in Emerging Markets
Based in Switzerland, MAEM is an independent global health organization dedicated to advancing dialogue and policy insight to improve access to safe and effective medicines across emerging markets.
Bridging Global Policy with Pharmaceutical Innovation
The MAEM Global Health Organization addresses medicines access challenges in emerging markets. By connecting global health policy with pharmaceutical innovation and improving health systems, we deliver equitable healthcare solutions across borders.
Strategy & Impact
Our Strategic Focus Areas
Policy Integration
Harmonizing international health policies with local regulatory landscapes to ensure seamless integration and legal compliance across emerging markets.
Innovation Delivery
Bridging the gap between pharmaceutical breakthroughs and patient access through specialized distribution models and market-specific delivery solutions.
System Resilience
Strengthening the foundations of local health systems to create sustainable, high-integrity supply chains that protect patient safety and medicine efficacy.
MARKET REACH
50+
Nations Connected
R&D NETWORK
120
Pharma Partners
ACCESS INDEX
24M
Patients Reached
POLICY FRAMEWORK